Clene Financials

CLNN Stock  USD 0.33  0.02  5.71%   
Based on the measurements of operating efficiency obtained from Clene's historical financial statements, Clene Inc is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. At this time, Clene's Property Plant Equipment is very stable compared to the past year. As of the 23rd of April 2024, Total Assets is likely to grow to about 53.5 M, while Other Liabilities is likely to drop about 2.2 M. Key indicators impacting Clene's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio1.461.5338
Notably Down
Pretty Stable
The financial analysis of Clene is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for Clene includes many different criteria found on its balance sheet. For example, investors should never minimize Clene's ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor Clene's cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in Clene.

Net Income

(47.03 Million)

With this module, you can analyze Clene financials for your investing period. You should be able to track the changes in Clene individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past Clene Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Clene's financial statements are interrelated, with each one affecting the others. For example, an increase in Clene's assets may result in an increase in income on the income statement.
The data published in Clene's official financial statements usually reflect Clene's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Clene Inc. For example, before you start analyzing numbers published by Clene accountants, it's critical to develop an understanding of what Clene's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Clene's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Clene's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Clene's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Clene Inc. Please utilize our Beneish M Score to check the likelihood of Clene's management manipulating its earnings.

Clene Stock Summary

Clene competes with MediciNova, Eliem Therapeutics, Molecular Partners, Champions Oncology, and Century Therapeutics. Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It also markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. Clene operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 95 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS1856341029
CUSIP185634102 G8959N106 G8959N130
LocationUtah; U.S.A
Business Address6550 South Millrock
SectorBiotechnology
IndustryHealth Care
BenchmarkNYSE Composite
Websiteclene.com
Phone801 676 9695
CurrencyUSD - US Dollar
You should never invest in Clene without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Clene Stock, because this is throwing your money away. Analyzing the key information contained in Clene's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Clene Key Financial Ratios

Generally speaking, Clene's financial ratios allow both analysts and investors to convert raw data from Clene's financial statements into concise, actionable information that can be used to evaluate the performance of Clene over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Clene Inc reports annually and quarterly.

Clene Key Balance Sheet Accounts

201920202021202220232024 (projected)
Other Current Liab2.9M10.0M3.6M3.9M3.7M4.4M
Net Tangible Assets(67.8M)341K12.6M3.2M3.7M3.9M
Retained Earnings(69.6M)(153.6M)(163.3M)(193.2M)(242.7M)(230.6M)
Accounts Payable889K1.1M1.9M3.0M1.5M1.8M
Total Current Assets9.5M63.0M54.6M29.2M38.9M38.9M

Clene Key Income Statement Accounts

An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket. The other reason investors look at the income statement is to determine what Clene's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
201920202021202220232024 (projected)
Interest Expense88K950K870K3.3M4.6M4.8M
Ebit(16.3M)(17.0M)(45.3M)(45.3M)(40.5M)(42.6M)

Clene Key Cash Accounts

Cash flow analysis captures how much money flows into and out of Clene Inc. It measures of how well Clene is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Clene brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Clene had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Clene has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
201920202021202220232024 (projected)
Change In Cash(8.0M)50.5M(8.9M)(32.0M)10.5M11.0M
Net Borrowings(2.6M)6.6M19.5M5.6M6.5M7.3M
Depreciation848K963K955K1.0M1.7M1.1M
Capital Expenditures294K387K1.3M5.2M330K313.5K
Net Income(16.2M)(19.3M)(9.7M)(29.9M)(49.5M)(47.0M)
End Period Cash Flow8.8M59.3M50.3M18.4M28.8M33.4M
Change To Netincome953K2.6M10.7M8.3M9.6M5.5M

Clene Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Clene's current stock value. Our valuation model uses many indicators to compare Clene value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Clene competition to find correlations between indicators driving Clene's intrinsic value. More Info.
Clene Inc is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . At this time, Clene's Return On Equity is very stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Clene by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Clene's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Clene's earnings, one of the primary drivers of an investment's value.

Clene Inc Systematic Risk

Clene's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Clene volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Clene Inc correlated with the market. If Beta is less than 0 Clene generally moves in the opposite direction as compared to the market. If Clene Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Clene Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Clene is generally in the same direction as the market. If Beta > 1 Clene moves generally in the same direction as, but more than the movement of the benchmark.

About Clene Financials

What exactly are Clene Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Clene's income statement, its balance sheet, and the statement of cash flows. Potential Clene investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Clene investors may use each financial statement separately, they are all related. The changes in Clene's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Clene's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Steps to analyze Clene Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Clene is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Clene has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Clene's financials are consistent with your investment objective using the following steps:
  • Review Clene's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Clene's liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Clene's financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Clene's stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.
Today, most investors in Clene Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Clene's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Clene growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(0.006327)

At this time, Clene's Price Earnings To Growth Ratio is very stable compared to the past year.

Clene April 23, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Clene help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Clene Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Clene Inc based on widely used predictive technical indicators. In general, we focus on analyzing Clene Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Clene's daily price indicators and compare them against related drivers.
When determining whether Clene Inc is a strong investment it is important to analyze Clene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clene's future performance. For an informed investment choice regarding Clene Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clene Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Clene Stock analysis

When running Clene's price analysis, check to measure Clene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clene is operating at the current time. Most of Clene's value examination focuses on studying past and present price action to predict the probability of Clene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clene's price. Additionally, you may evaluate how the addition of Clene to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Fundamental Analysis
View fundamental data based on most recent published financial statements
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Is Clene's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clene. If investors know Clene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.614
Earnings Share
(0.47)
Revenue Per Share
0.006
Quarterly Revenue Growth
(0.27)
Return On Assets
(0.52)
The market value of Clene Inc is measured differently than its book value, which is the value of Clene that is recorded on the company's balance sheet. Investors also form their own opinion of Clene's value that differs from its market value or its book value, called intrinsic value, which is Clene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clene's market value can be influenced by many factors that don't directly affect Clene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.